<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">endoserg</journal-id><journal-title-group><journal-title xml:lang="ru">Эндокринная хирургия</journal-title><trans-title-group xml:lang="en"><trans-title>Endocrine Surgery</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2306-3513</issn><issn pub-type="epub">2310-3965</issn><publisher><publisher-name>Типография «Печатных дел Мастер»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/serg12825</article-id><article-id custom-type="elpub" pub-id-type="custom">endoserg-12825</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальное исследование</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original study</subject></subj-group></article-categories><title-group><article-title>МРТ без контрастного усиления — высокоточный метод визуализации инсулиномы</article-title><trans-title-group xml:lang="en"><trans-title>MRI without contrast enhancement is a highly accurate method of imaging insulinoma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8771-8300</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юкина</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Yukina</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юкина Марина Юрьевна - к.м.н.</p><p>117292, Москва, ул. Дмитрия Ульянова, д. 11; Researcher ID: P-5181-2015; Scopus Author ID: 57109367700</p></bio><bio xml:lang="en"><p>Marina Yu. Yukina - MD, PhD.</p><p>117292, Москва, ул. Дмитрия Ульянова, д. 11; Researcher ID: P-5181-2015; Scopus Author ID: 57109367700</p></bio><email xlink:type="simple">yukina.ERC@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8520-8702</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Трошина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Troshina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Трошина Екатерина Анатольевна - д.м.н., профессор.</p><p>Москва</p></bio><bio xml:lang="en"><p>Ekaterina A. Troshina - MD, PhD, Professor.</p><p>Moscow</p></bio><email xlink:type="simple">troshina.ekaterina@endocrincentr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6876-3336</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нуралиева</surname><given-names>Н. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Nuralieva</surname><given-names>N. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нуралиева Нурана Фейзуллаевна - к.м.н.</p><p>Москва</p></bio><bio xml:lang="en"><p>Nurana F. Nuralieva - MD, PhD.</p><p>Moscow</p></bio><email xlink:type="simple">nuralieva.nurana@endocrincentr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7965-9454</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарбаева</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarbaeva</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тарбаева Наталья Викторовна - к.м.н.</p><p>Москва</p></bio><bio xml:lang="en"><p>Natalya V. Tarbaeva - MD, PhD.</p><p>Moscow</p></bio><email xlink:type="simple">Tarbaeva.Natalya@endocrincentr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6733-0958</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Реброва</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rebrova</surname><given-names>O. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Реброва Ольга Юрьевна - д.м.н.</p><p>Москва</p></bio><bio xml:lang="en"><p>Olga Yu. Rebrova - MD, PhD.</p><p>Moscow</p></bio><email xlink:type="simple">rebrova.olga@endocrincentr.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9717-9742</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мокрышева</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Mokrysheva</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мокрышева Наталья Георгиевна - д.м.н., профессор.</p><p>Москва</p></bio><bio xml:lang="en"><p>Natalia G. Mokrysheva - MD, PhD, Professor.</p><p>Moscow</p></bio><email xlink:type="simple">mokrisheva.natalia@endocrincentr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Государственный научный центр Российской Федерации Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр эндокринологии»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Государственный научный центр Российской Федерации Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр эндокринологии»; Федеральное государственное автономное образовательное учреждение высшего образования «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre; Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>09</day><month>12</month><year>2024</year></pub-date><volume>18</volume><issue>3</issue><fpage>24</fpage><lpage>35</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Юкина М.Ю., Трошина Е.А., Нуралиева Н.Ф., Тарбаева Н.В., Реброва О.В., Мокрышева Н.Г., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Юкина М.Ю., Трошина Е.А., Нуралиева Н.Ф., Тарбаева Н.В., Реброва О.В., Мокрышева Н.Г.</copyright-holder><copyright-holder xml:lang="en">Yukina M.Y., Troshina E.A., Nuralieva N.F., Tarbaeva N.V., Rebrova O.Y., Mokrysheva N.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.surg-endojournals.ru/jour/article/view/12825">https://www.surg-endojournals.ru/jour/article/view/12825</self-uri><abstract><sec><title>ОБОСНОВАНИЕ</title><p>ОБОСНОВАНИЕ. Согласно литературным источникам, имеются противоречивые результаты относительно диагностической точности магнитно-резонансной томографии (МРТ) без контрастного усиления (к/у) при инсулиноме, а исследования, которые анализируют факторы, влияющие на получение ложноотрицательных результатов, не описаны. ЦЕЛЬ. Оценка операционных характеристик МРТ без к/у при визуализации инсулиномы.</p></sec><sec><title>МАТЕРИАЛЫ И МЕТОДЫ</title><p>МАТЕРИАЛЫ И МЕТОДЫ. Пациентам с подозрением на недиабетическую гипогликемию (НДГ) выполнены визуализирующие исследования органов брюшной полости и забрюшинного пространства: МРТ без к/у (индексный тест) и КТ с к/у (референсный тест первого ряда). В качестве референсного теста второго ряда применялось ультразвуковое исследование, третьего ряда — артериально-стимулированный венозный забор крови. Диагноз НДГ и инсулиномы устанавливался на основании выявления гиперинсулинемической гипогликемии в ходе лабораторного обследования и подтверждения наличия опухоли поджелудочной железы.</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ. Включено 125 пациентов с инсулиномой и 55 пациентов с прочими причинами НДГ. Чувствительность МРТ без к/у в диагностике инсулиномы составила 94%, 95% ДИ [89%; 98%], специфичность — 98%, 95% ДИ [90%; 100%], прогностическая ценность положительного результата — 99%, 95% ДИ [95%; 100%], прогностическая ценность отрицательного результата — 87%, 95% ДИ [76%; 94%]. Индекс Kappa согласия с заключительным диагнозом составил 0,886 (95% ДИ [0,814; 0,958]), что соответствует отличному согласию, с КТ — 0,750 (95% ДИ [0,651; 0,850]), что соответствует существенному согласию.</p><p>При сравнительном анализе томографических и патоморфологических характеристик инсулиномы, в случаях с расхождением результатов при применении МРТ без к/у и КТ с к/у, значимых отличий по структуре, форме, особенностям контуров, локализации и степени злокачественности опухоли, а также структуре окружающей ее паренхимы не выявлено.</p><p>В представленной выборке инсулинома имеет медиану размера 14–15 мм, медиану оптической плотности в нативную фазу КТ 42–44 ед.Н, гиперинтенсивность на Т2-взвешенных изображениях МРТ в 89%, 95% ДИ [78%; 95%] случаев и низкую степень злокачественности Grade 1 в 70%, 95% ДИ [56%; 81%] случаев.</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ. КТ с к/у и МРТ без к/у характеризуются существенным согласием в диагностике инсулиномы. В связи с этим, а также ввиду отсутствия лучевой нагрузки и строгой необходимости введения контрастных веществ, МРТ без к/у может быть рекомендована в качестве метода первого ряда наравне с абдоминальным УЗИ и КТ с к/у для выявления инсулиномы.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>BACKGROUND</title><p>BACKGROUND: According to the literature, there are contradictory results regarding the diagnostic accuracy of magnetic resonance imaging (MRI) without contrast enhancement (CE) in insulinoma, and studies that analyze the factors influencing the obtaining of false negative results have not been described.</p></sec><sec><title>AIM</title><p>AIM: Evaluation of the operational characteristics of MRI imaging of insulinoma without CE.</p></sec><sec><title>MATERIALS AND METHODS</title><p>MATERIALS AND METHODS: Imaging studies of the abdominal cavity and retroperitoneal space were performed in patients with suspected nondiabetic hypoglycemia (NDH): MRI without CE (index test) and CT with CE (first row reference test). Ultrasound examination was used as a reference test of the second row, and arteriostimulated venous blood sampling was used in the third row. The diagnosis of NDH and insulinoma was established based on the detection of hyperinsulinemic hypoglycemia during laboratory examination and confirmation of the presence of a pancreatic tumor.</p></sec><sec><title>RESULTS</title><p>RESULTS: 125 patients with insulinoma and 55 patients with other causes of NDH were included. The sensitivity of MRI without CE in the diagnosis of insulinoma was 94%, 95% CI [89%; 98%], specificity — 98%, 95% CI [90%; 100%], prognostic value of a positive result — 99%, 95% CI [95%; 100%], prognostic value of a negative result is 87%, 95% CI [76%; 94%]. The Kappa index of agreement with the final diagnosis was 0.886 (95% CI [0.814; 0.958]), which corresponds to excellent agreement, with CT — 0.750 (95% CI [0.651; 0.850]), which corresponds to significant agreement.</p><p>In a comparative analysis of the tomographic and pathomorphological characteristics of insulinoma, in cases with divergent results when using MRI without CE and CT with CE, significant differences in structure, shape, contour features, localization and degree of malignancy of the tumor, as well as the structure of its surrounding parenchyma were not revealed.</p><p>In the presented sample, the insulinoma has a median size of 14–15 mm with the median optical density in the native phase of CT 42–44 units.H, hyperintensivity on T2-weighted MRI images in 89%, 95% CI [78%; 95%] cases and low Grade 1 malignancy in 70%, 95% CI [56%; 81%] cases.</p></sec><sec><title>CONCLUSION</title><p>CONCLUSION: CT with CE and MRI without CE are characterized by significant agreement in the diagnosis of insulinoma. In this regard, as well as due to the lack of radiation exposure and the strict need for contrast agents, MRI without CE can be recommended as a first-line method on a par with abdominal ultrasound and CT with CE to detect insulinoma.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>инсулинома</kwd><kwd>компьютерная томография</kwd><kwd>магнитно-резонансная томография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>insulinoma</kwd><kwd>computed tomography</kwd><kwd>magnetic resonance imaging</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено при поддержке гранта Министерства науки и высшего образования Российской Федерации (соглашение №075-15-2022-310 от 20.04.2022)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao K, Patel N, Kulkarni K, et al. Essentials of insulinoma localization with selective arterial calcium stimulation and hepatic venous sampling. Journal of Clinical Medicine. 2020;9(10):1–14. doi: https://doi.org/10.3390/jcm9103091</mixed-citation><mixed-citation xml:lang="en">Zhao K, Patel N, Kulkarni K, et al. Essentials of insulinoma localization with selective arterial calcium stimulation and hepatic venous sampling. Journal of Clinical Medicine. 2020;9(10):1–14. doi: https://doi.org/10.3390/jcm9103091</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Fu J, Zhang J, Wang Y, et al. Comparison of angio-CT versus multidetector CT in the detection and location for insulinomas. Clinical Radiology. 2020;75(10):796.e11-796.e16. doi: https://doi.org/10.1016/j.crad.2020.05.012</mixed-citation><mixed-citation xml:lang="en">Fu J, Zhang J, Wang Y, et al. Comparison of angio-CT versus multidetector CT in the detection and location for insulinomas. Clinical Radiology. 2020;75(10):796.e11-796.e16. doi: https://doi.org/10.1016/j.crad.2020.05.012</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">An L, Li W, Yao KC, et al. Assessment of contrast-enhanced ultrasonography in diagnosis and preoperative localization of insulinoma. Eur J Radiol. 2011;80(3):675-680. doi: https://doi.org/10.1016/j.ejrad.2010.09.014</mixed-citation><mixed-citation xml:lang="en">An L, Li W, Yao KC, et al. Assessment of contrast-enhanced ultrasonography in diagnosis and preoperative localization of insulinoma. Eur J Radiol. 2011;80(3):675-680. doi: https://doi.org/10.1016/j.ejrad.2010.09.014</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">McAuley G, Delaney H, Colville J, et al. Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol. 2005;60(10):1039-1050. doi: https://doi.org/10.1016/j.crad.2005.06.005</mixed-citation><mixed-citation xml:lang="en">McAuley G, Delaney H, Colville J, et al. Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol. 2005;60(10):1039-1050. doi: https://doi.org/10.1016/j.crad.2005.06.005</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mehrabi A, Fischer L, Hafezi M, et al. A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas. 2014. doi: https://doi.org/10.1097/MPA.0000000000000110</mixed-citation><mixed-citation xml:lang="en">Mehrabi A, Fischer L, Hafezi M, et al. A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas. 2014. doi: https://doi.org/10.1097/MPA.0000000000000110</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu L, Xue H, Sun H, et al. Insulinoma detection with MDCT: Is there a role for whole-pancreas perfusion? American Journal of Roentgenology. 2017;208(2):306–314. doi: https://doi.org/10.2214/AJR.16.16351</mixed-citation><mixed-citation xml:lang="en">Zhu L, Xue H, Sun H, et al. Insulinoma detection with MDCT: Is there a role for whole-pancreas perfusion? American Journal of Roentgenology. 2017;208(2):306–314. doi: https://doi.org/10.2214/AJR.16.16351</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lin XZ, Wu ZY, Tao R, et al. Dual energy spectral CT imaging of insulinoma Value in preoperative diagnosis compared with conventional multi-detector CT. European Journal of Radiology. 2012;81(10):2487–2494. doi: https://doi.org/10.1016/j.ejrad.2011.10.028</mixed-citation><mixed-citation xml:lang="en">Lin XZ, Wu ZY, Tao R, et al. Dual energy spectral CT imaging of insulinoma Value in preoperative diagnosis compared with conventional multi-detector CT. European Journal of Radiology. 2012;81(10):2487–2494. doi: https://doi.org/10.1016/j.ejrad.2011.10.028</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Song P, Yan JY, Wang Y, Li X. Value of multi-detector computed tomography during intra-arterial infusion of contrast medium for locating insulinomas. Journal of International Medical Research. 2020;48(3). doi: https://doi.org/10.1177/0300060519889432</mixed-citation><mixed-citation xml:lang="en">Song P, Yan JY, Wang Y, Li X. Value of multi-detector computed tomography during intra-arterial infusion of contrast medium for locating insulinomas. Journal of International Medical Research. 2020;48(3). doi: https://doi.org/10.1177/0300060519889432</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Yang Y, Shi J, Zhu J. Diagnostic performance of noninvasive imaging modalities for localization of insulinoma: A meta-analysis. European Journal of Radiology. 2021;145. doi: https://doi.org/10.1016/j.ejrad.2021.110016</mixed-citation><mixed-citation xml:lang="en">Yang Y, Shi J, Zhu J. Diagnostic performance of noninvasive imaging modalities for localization of insulinoma: A meta-analysis. European Journal of Radiology. 2021;145. doi: https://doi.org/10.1016/j.ejrad.2021.110016</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Antwi K, Fani M, Heye T, et al. Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study. European Journal of Nuclear Medicine and Molecular Imaging. 2018;45(13):2318–2327. doi: https://doi.org/10.1007/s00259-018-4101-5</mixed-citation><mixed-citation xml:lang="en">Antwi K, Fani M, Heye T, et al. Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study. European Journal of Nuclear Medicine and Molecular Imaging. 2018;45(13):2318–2327. doi: https://doi.org/10.1007/s00259-018-4101-5</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hasanov R, Samadov E, Bayramov N, et al. Surgical management of insulinomas at the Azerbaijan medical university: A retrospective study of 21 cases over a 10-year period. Turkish Journal of Medical Sciences. 2020;50(5):1262–1269. doi: https://doi.org/10.3906/sag-2001-150</mixed-citation><mixed-citation xml:lang="en">Hasanov R, Samadov E, Bayramov N, et al. Surgical management of insulinomas at the Azerbaijan medical university: A retrospective study of 21 cases over a 10-year period. Turkish Journal of Medical Sciences. 2020;50(5):1262–1269. doi: https://doi.org/10.3906/sag-2001-150</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Daneshvar K, Grenacher L, Mehrabi A, et al. Preoperative tumor studies using MRI or CT in patients with clinically suspected insulinoma. Pancreatology. 2011;11(5):487–495. doi: https://doi.org/10.1159/000330208</mixed-citation><mixed-citation xml:lang="en">Daneshvar K, Grenacher L, Mehrabi A, et al. Preoperative tumor studies using MRI or CT in patients with clinically suspected insulinoma. Pancreatology. 2011;11(5):487–495. doi: https://doi.org/10.1159/000330208</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Owen NJ, Sohaib SAA, Peppercorn PD, et al. MRI of pancreatic neuroendocrine tumours. Br J Radiol. 2001;74(886):968-973. doi: https://doi.org/10.1259/bjr.74.886.740968</mixed-citation><mixed-citation xml:lang="en">Owen NJ, Sohaib SAA, Peppercorn PD, et al. MRI of pancreatic neuroendocrine tumours. Br J Radiol. 2001;74(886):968-973. doi: https://doi.org/10.1259/bjr.74.886.740968</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of Small, Functional Islet Cell Tumors in the Pancreas: Selection of MR Imaging Sequences for Optimal Sensitivity. Radiology. 2000;214(2):483-490. doi: https://doi.org/10.1148/radiology.214.2.r00fe32483</mixed-citation><mixed-citation xml:lang="en">Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of Small, Functional Islet Cell Tumors in the Pancreas: Selection of MR Imaging Sequences for Optimal Sensitivity. Radiology. 2000;214(2):483-490. doi: https://doi.org/10.1148/radiology.214.2.r00fe32483</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">He M, Xu J, Sun Z, et al. Prospective Comparison of Reduced Field-of-View (rFOV) and Full FOV (fFOV) Diffusion-Weighted Imaging (DWI) in the Assessment of Insulinoma: Image Quality and Lesion Detection. Acad Radiol. 2020;27(11):1572-1579. doi: https://doi.org/10.1016/j.acra.2019.11.019</mixed-citation><mixed-citation xml:lang="en">He M, Xu J, Sun Z, et al. Prospective Comparison of Reduced Field-of-View (rFOV) and Full FOV (fFOV) Diffusion-Weighted Imaging (DWI) in the Assessment of Insulinoma: Image Quality and Lesion Detection. Acad Radiol. 2020;27(11):1572-1579. doi: https://doi.org/10.1016/j.acra.2019.11.019</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu L, Xue H, Sun Z, et al. Prospective comparison of biphasic contrast‐enhanced CT, volume perfusion CT, and 3 Tesla MRI with diffusion‐weighted imaging for insulinoma detection. J Magn Reson Imaging. 2017;46(6):1648-1655. doi: https://doi.org/10.1002/jmri.25709</mixed-citation><mixed-citation xml:lang="en">Zhu L, Xue H, Sun Z, et al. Prospective comparison of biphasic contrast‐enhanced CT, volume perfusion CT, and 3 Tesla MRI with diffusion‐weighted imaging for insulinoma detection. J Magn Reson Imaging. 2017;46(6):1648-1655. doi: https://doi.org/10.1002/jmri.25709</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Jyotsna VP, Pal S, Kandasamy D, et al. Evolving management of insulinoma: Experience at a tertiary care centre. Indian Journal of Medical Research. 2016;144:771–777. doi: https://doi.org/10.4103/ijmr.IJMR_1477_14</mixed-citation><mixed-citation xml:lang="en">Jyotsna VP, Pal S, Kandasamy D, et al. Evolving management of insulinoma: Experience at a tertiary care centre. Indian Journal of Medical Research. 2016;144:771–777. doi: https://doi.org/10.4103/ijmr.IJMR_1477_14</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Krieger AG, Smirnov AV, Berelavichus SV, et al. Organic hyperinsulinism: radiological diagnostics and surgical treatment. Khirurgiia (Mosk). 2016;(6):14-29. doi: https://doi.org/10.17116/hirurgia2016614-22</mixed-citation><mixed-citation xml:lang="en">Krieger AG, Smirnov AV, Berelavichus SV, et al. Organic hyperinsulinism: radiological diagnostics and surgical treatment. Khirurgiia (Mosk). 2016;(6):14-29. doi: https://doi.org/10.17116/hirurgia2016614-22</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Andreassen M, Ilett E, Wiese D, et al. Surgical Management, Preoperative Tumor Localization, and Histopathology of 80 Patients Operated on for Insulinoma. J Clin Endocrinol Metab. 2019;104(12):6129-6138. doi: https://doi.org/10.1210/jc.2019-01204</mixed-citation><mixed-citation xml:lang="en">Andreassen M, Ilett E, Wiese D, et al. Surgical Management, Preoperative Tumor Localization, and Histopathology of 80 Patients Operated on for Insulinoma. J Clin Endocrinol Metab. 2019;104(12):6129-6138. doi: https://doi.org/10.1210/jc.2019-01204</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Angeli E, Vanzulli A, Castrucci M, et al. Value of abdominal sonography and MR imaging at 0.5 T in preoperative detection of pancreatic insulinoma: a comparison with dynamic CT and angiography. Abdom Imaging. 1997;22(3):295-303. doi: https://doi.org/10.1007/s002619900193</mixed-citation><mixed-citation xml:lang="en">Angeli E, Vanzulli A, Castrucci M, et al. Value of abdominal sonography and MR imaging at 0.5 T in preoperative detection of pancreatic insulinoma: a comparison with dynamic CT and angiography. Abdom Imaging. 1997;22(3):295-303. doi: https://doi.org/10.1007/s002619900193</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Shi Z, Li X, You R, et al. Homogenously isoattenuating insulinoma on biphasic contrast-enhanced computed tomography: Little benefits of diffusion-weighted imaging for lesion detection. Oncol Lett. 2018;16(3):3117-3125. doi: https://doi.org/10.3892/ol.2018.9037</mixed-citation><mixed-citation xml:lang="en">Shi Z, Li X, You R, et al. Homogenously isoattenuating insulinoma on biphasic contrast-enhanced computed tomography: Little benefits of diffusion-weighted imaging for lesion detection. Oncol Lett. 2018;16(3):3117-3125. doi: https://doi.org/10.3892/ol.2018.9037</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Anaye A, Mathieu A, Closset J, et al. Successful preoperative localization of a small pancreatic insulinoma by diffusion-weighted MRI. JOP. 2009;10(5):528-31</mixed-citation><mixed-citation xml:lang="en">Anaye A, Mathieu A, Closset J, et al. Successful preoperative localization of a small pancreatic insulinoma by diffusion-weighted MRI. JOP. 2009;10(5):528-31</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009;94(3):709-28. doi: https://doi.org/10.1210/jc.2008-1410</mixed-citation><mixed-citation xml:lang="en">Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009;94(3):709-28. doi: https://doi.org/10.1210/jc.2008-1410</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Нейроэндокринные опухоли. Клинические рекомендации. 2020 г. Available from: https://cr.minzdrav.gov.ru/recomend/610_1</mixed-citation><mixed-citation xml:lang="en">Nejroendokrinnye opuholi. Klinicheskie rekomendacii. 2020 (In Russ.)] Available from: https://cr.minzdrav.gov.ru/recomend/610_1</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ponzi E, Maiorana A, Lepri FR, et al. Persistent Hypoglycemia in Children: Targeted Gene Panel Improves the Diagnosis of Hypoglycemia Due to Inborn Errors of Metabolism. J Pediatr. 2018;202:272-8. doi: https://doi.org/10.1016/j.jpeds.2018.06.050</mixed-citation><mixed-citation xml:lang="en">Ponzi E, Maiorana A, Lepri FR, et al. Persistent Hypoglycemia in Children: Targeted Gene Panel Improves the Diagnosis of Hypoglycemia Due to Inborn Errors of Metabolism. J Pediatr. 2018;202:272-8. doi: https://doi.org/10.1016/j.jpeds.2018.06.050</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Cavalcanti MS, Gönen M, Klimstra DS. The ENETS/WHO grading system for neuroendocrine neoplasms of the gastroenteropancreatic system: a review of the current state, limitations and proposals for modifications. Int J Endocr Oncol. 2016;3(3):203-219. doi: https://doi.org/10.2217/ije-2016-0006</mixed-citation><mixed-citation xml:lang="en">Cavalcanti MS, Gönen M, Klimstra DS. The ENETS/WHO grading system for neuroendocrine neoplasms of the gastroenteropancreatic system: a review of the current state, limitations and proposals for modifications. Int J Endocr Oncol. 2016;3(3):203-219. doi: https://doi.org/10.2217/ije-2016-0006</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174. doi: https://doi.org/10.2307/2529310.</mixed-citation><mixed-citation xml:lang="en">Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174. doi: https://doi.org/10.2307/2529310.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Егоров А.В., Мусаев Г.Х., Фоминых Е.В., Кондрашин С.А., Парнова В.А., и др. Эволюция алгоритма топической диагностики гормонально-активных нейроэндокринных опухолей поджелудочной железы // Анналы хирургической гепатологии. 2016. — Т. 21. — №1. — С. 21-27. doi: https://doi.org/10.16931/1995-5464.2016121-27</mixed-citation><mixed-citation xml:lang="en">Egorov AV, Musaev GKh, Fominykh EV, Kondrashin SA, Parnova VA, et al. Evolution of topical diagnostic algorithm for pancreatic hormoneproducing neuroendocrine tumors. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2016;21(1):21-27. (In Russ.) doi: https://doi.org/10.16931/1995-5464.2016121-27</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Fu J, Liu F, Yuan K, et al. The Value of Hybrid Angio-CT in Preoperative Detection and Localization of Insulinomas: A Single-Center Retrospective Study. Cardiovasc Intervent Radiol. 2018;41(4):633-638. doi: https://doi.org/10.1007/s00270-017-1847-2</mixed-citation><mixed-citation xml:lang="en">Fu J, Liu F, Yuan K, et al. The Value of Hybrid Angio-CT in Preoperative Detection and Localization of Insulinomas: A Single-Center Retrospective Study. Cardiovasc Intervent Radiol. 2018;41(4):633-638. doi: https://doi.org/10.1007/s00270-017-1847-2</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Druce MR, Muthuppalaniappan VM, O’Leary B, et al. Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterization. Eur J Endocrinol. 2010;162(5):971-8. doi: https://doi.org/10.1530/EJE-10-0056</mixed-citation><mixed-citation xml:lang="en">Druce MR, Muthuppalaniappan VM, O’Leary B, et al. Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterization. Eur J Endocrinol. 2010;162(5):971-8. doi: https://doi.org/10.1530/EJE-10-0056</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Crippa S, Zerbi A, Boninsegna L, et al. Surgical management of insulinomas: shortand long-term outcomes after enucleations and pancreatic resections. Arch Surg. 2012;147(3):261-6. doi: https://doi.org/10.1001/archsurg.2011.1843</mixed-citation><mixed-citation xml:lang="en">Crippa S, Zerbi A, Boninsegna L, et al. Surgical management of insulinomas: shortand long-term outcomes after enucleations and pancreatic resections. Arch Surg. 2012;147(3):261-6. doi: https://doi.org/10.1001/archsurg.2011.1843</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Хацимова Л.С., Каронова Т.Л., Цой У.А., Яневская Л.Г., Гринева Е.Н. Инсулинома: диагностические подходы и врачебная тактика // Проблемы эндокринологии. — 2017. — Т. 63. — №4. — С. 212—218. doi: https://doi.org/10.14341/probl2017634212-218</mixed-citation><mixed-citation xml:lang="en">Khacimova LS, Karonova TL, Tsoy UA, Ianevskaia LG, Grineva EN. Insulinoma: diagnostic features and treatment management. Problems of Endocrinology. 2017;63(4):212-218. (In Russ.) doi: https://doi.org/10.14341/probl2017634212-218</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Nikfarjam M, Warshaw AL, Axelrod L, et al. Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg. 2008;247(1):165-72. doi: https://doi.org/10.1097/SLA.0b013e31815792ed</mixed-citation><mixed-citation xml:lang="en">Nikfarjam M, Warshaw AL, Axelrod L, et al. Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg. 2008;247(1):165-72. doi: https://doi.org/10.1097/SLA.0b013e31815792ed</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Inan N, Arslan A, Akansel G, et al. Unusual magnetic resonance image of an insulinoma with extensive desmoplastic reaction. JOP. 2008;9(1):61-6</mixed-citation><mixed-citation xml:lang="en">Inan N, Arslan A, Akansel G, et al. Unusual magnetic resonance image of an insulinoma with extensive desmoplastic reaction. JOP. 2008;9(1):61-6</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Afonso PD, Duarte S, Barata MJ, Camacho R. A type of pancreatic islet cell tumor: Insulinoma. A case report. 2007. doi: https://doi.org/10.1594/EURORAD/CASE.6144</mixed-citation><mixed-citation xml:lang="en">Afonso PD, Duarte S, Barata MJ, Camacho R. A type of pancreatic islet cell tumor: Insulinoma. A case report. 2007. doi: https://doi.org/10.1594/EURORAD/CASE.6144</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Sundin A, Arnold R, Baudin E, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging. In: Neuroendocrinology. 2017. doi: https://doi.org/10.1159/000471879</mixed-citation><mixed-citation xml:lang="en">Sundin A, Arnold R, Baudin E, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging. In: Neuroendocrinology. 2017. doi: https://doi.org/10.1159/000471879</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Khanna L, Prasad SR, Sunnapwar A, et al. Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification. Radiographics. 2020;40(5):1240-1262. doi: https://doi.org/10.1148/rg.2020200025</mixed-citation><mixed-citation xml:lang="en">Khanna L, Prasad SR, Sunnapwar A, et al. Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification. Radiographics. 2020;40(5):1240-1262. doi: https://doi.org/10.1148/rg.2020200025</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">AlJadir S. Insulinoma: Literature’s Review (2). Endocrinol Int J. 2015. doi: https://doi.org/10.15406/emij.2015.02.00031</mixed-citation><mixed-citation xml:lang="en">AlJadir S. Insulinoma: Literature’s Review (2). Endocrinol Int J. 2015. doi: https://doi.org/10.15406/emij.2015.02.00031</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Sumarac-Dumanovic M, Micic D, Krstic M, et al. Pitfalls in diagnosing a small cystic insulinoma: a case report. J Med Case Rep. 2007:1:181. doi: https://doi.org/10.1186/1752-1947-1-181</mixed-citation><mixed-citation xml:lang="en">Sumarac-Dumanovic M, Micic D, Krstic M, et al. Pitfalls in diagnosing a small cystic insulinoma: a case report. J Med Case Rep. 2007:1:181. doi: https://doi.org/10.1186/1752-1947-1-181</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Tamagno G, Maffei P, Pasquali C, et al. Clinical and diagnostic aspects of cystic insulinoma. Scand J Gastroenterol. 2005;40(12):1497-501. doi: https://doi.org/10.1080/00365520510024160</mixed-citation><mixed-citation xml:lang="en">Tamagno G, Maffei P, Pasquali C, et al. Clinical and diagnostic aspects of cystic insulinoma. Scand J Gastroenterol. 2005;40(12):1497-501. doi: https://doi.org/10.1080/00365520510024160</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Kou HW, Yu MC, Chong SW, Hsu HY, Chou HH, et al. Successful Localization and Resection of Small Pancreatic Cystic Insulinoma Using Intraoperative Near-Infrared Fluorescence Imaging: A Case Report and Literature Review. Pancreas. 2020;49(10):1388-1392. doi: https://doi.org/10.1097/MPA.0000000000001678</mixed-citation><mixed-citation xml:lang="en">Kou HW, Yu MC, Chong SW, Hsu HY, Chou HH, et al. Successful Localization and Resection of Small Pancreatic Cystic Insulinoma Using Intraoperative Near-Infrared Fluorescence Imaging: A Case Report and Literature Review. Pancreas. 2020;49(10):1388-1392. doi: https://doi.org/10.1097/MPA.0000000000001678</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Balci NC, Semelka RC. Radiologic features of cystic, endocrine and other pancreatic neoplasms. Eur J Radiol. 2001;38(2):113-9. doi: https://doi.org/10.1016/s0720-048x(01)00296-0</mixed-citation><mixed-citation xml:lang="en">Balci NC, Semelka RC. Radiologic features of cystic, endocrine and other pancreatic neoplasms. Eur J Radiol. 2001;38(2):113-9. doi: https://doi.org/10.1016/s0720-048x(01)00296-0</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Okabayashi T, Shima Y, Sumiyoshi T, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19(6):829-37. doi: https://doi.org/10.3748/wjg.v19.i6.829</mixed-citation><mixed-citation xml:lang="en">Okabayashi T, Shima Y, Sumiyoshi T, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19(6):829-37. doi: https://doi.org/10.3748/wjg.v19.i6.829</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Kann P, Bittinger F, Engelbach M, et al. Endosonography of insulinsecreting and clinically non-functioning neuroendocrine tumors of the pancreas: criteria for benignancy and malignancy. Eur J Med Res. 2001;6(9):385-90</mixed-citation><mixed-citation xml:lang="en">Kann P, Bittinger F, Engelbach M, et al. Endosonography of insulinsecreting and clinically non-functioning neuroendocrine tumors of the pancreas: criteria for benignancy and malignancy. Eur J Med Res. 2001;6(9):385-90</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Noone TC, Hosey J, Firat Z, Semelka RC, et al. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab. 2005;19(2):195-211. doi: https://doi.org/10.1016/j.beem.2004.11.013</mixed-citation><mixed-citation xml:lang="en">Noone TC, Hosey J, Firat Z, Semelka RC, et al. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab. 2005;19(2):195-211. doi: https://doi.org/10.1016/j.beem.2004.11.013</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Taieb D, Legmann P, Prat F, et al. Topographic diagnosis: respective roles of morphological and functional imaging. Ann Endocrinol (Paris). 2013;74(3):185-190. doi: https://doi.org/10.1016/j.ando.2013.05.008</mixed-citation><mixed-citation xml:lang="en">Taieb D, Legmann P, Prat F, et al. Topographic diagnosis: respective roles of morphological and functional imaging. Ann Endocrinol (Paris). 2013;74(3):185-190. doi: https://doi.org/10.1016/j.ando.2013.05.008</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Ciaravino V, De Robertis R, Tinazzi Martini P, et al. Imaging presentation of pancreatic neuroendocrine neoplasms. Insights Imaging. 2018;9(6):943-953. doi: https://doi.org/10.1007/s13244-018-0658-6</mixed-citation><mixed-citation xml:lang="en">Ciaravino V, De Robertis R, Tinazzi Martini P, et al. Imaging presentation of pancreatic neuroendocrine neoplasms. Insights Imaging. 2018;9(6):943-953. doi: https://doi.org/10.1007/s13244-018-0658-6</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Matondanga S, Suwitaa BM, Budiantoa T, Krisnuhonib E. Atypical CT and MR imaging of insulinoma: A case report. Journal of Clinical and Translational Endocrinology: Case Reports. 2021;19:100075. doi: https://doi.org/10.1016/j.jecr.2020.100075</mixed-citation><mixed-citation xml:lang="en">Matondanga S, Suwitaa BM, Budiantoa T, Krisnuhonib E. Atypical CT and MR imaging of insulinoma: A case report. Journal of Clinical and Translational Endocrinology: Case Reports. 2021;19:100075. doi: https://doi.org/10.1016/j.jecr.2020.100075</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Agrawal N, Kar SS, Singh A, et al. Diffusion-weighted MRI in Localization of Insulinoma. Indian J Endocrinol Metab. 2020;24(2):222-224. doi: https://doi.org/10.4103/ijem.IJEM_636_19</mixed-citation><mixed-citation xml:lang="en">Agrawal N, Kar SS, Singh A, et al. Diffusion-weighted MRI in Localization of Insulinoma. Indian J Endocrinol Metab. 2020;24(2):222-224. doi: https://doi.org/10.4103/ijem.IJEM_636_19</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Soyoye DO, Atolani SA, Adetunji TA, Alatise OI. Insulinoma Presenting as Seizures: Challenges of Managing a Rare Disease in a Resource-challenged Setting. JCEM Case Rep. 2023;2(1):luad162. doi: https://doi.org/10.1210/jcemcr/luad162</mixed-citation><mixed-citation xml:lang="en">Soyoye DO, Atolani SA, Adetunji TA, Alatise OI. Insulinoma Presenting as Seizures: Challenges of Managing a Rare Disease in a Resource-challenged Setting. JCEM Case Rep. 2023;2(1):luad162. doi: https://doi.org/10.1210/jcemcr/luad162</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
